Clinical Trials

Clinical trials are research studies that test whether new medical treatments, devices or strategies  are safe and effective.

People who volunteer for clinical trials play an active role in their own health care, often gain access to experimental treatments, and help others by improving and advancing medical care.

At Providence Cancer Center, our scientists and physicians work closely together to make clinical trials a regular part of cancer care. Patients may take part in studies initiated by our translational researchers at the Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute, in addition to studies sponsored by the National Cancer Institute or pharmaceutical and biotechnology companies.

Our clinical trials team works directly with physicians to identify clinical trials appropriate for their patients’ specific stage of disease.

The goals of clinical research vary from trial to trial. Generally, they are designed to:

  • Improve prevention, early diagnosis and treatment of cancer
  • Discover whether a particular drug  or medical treatment is safe and effective
  • Advance the state of scientific and medical knowledge
  • Measure and improve the quality of life for patients and their families
Find cancer clinical trials available in Oregon in the list below. You may search by keyword or condition/disease, or browse using the page numbers and arrows. To learn more about a particular trial and qualification criteria, click the trial name and then the listed contact link, or talk with your physician.

For more information about clinical trials available through Providence Cancer Center, call 503-215-6014

« Previous 12345 Next »
Viewing Page 1 of 19 | Showing Results 1 - 5 of 93

A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, Alliance IND #15380) Vaccine Given with Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)

This is a phase III trial of HSPPC-96 in which patients will be randomized to one of three treatment arms: HSPPC-96 vaccine at the same time as...

Alison Conlin MD
  • Clackamas Radiation Oncology Center
  • Oncology and Hematology Care Southeast
  • Providence Newberg Medical Center
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
  • Providence Willamette Falls Medical Center

Phase I Study of Safety and Immunogenicity of ADU-623, a live-attenuated Listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRvIII and NY-ESO-1, in Patients with Treated and Recurrent WHO Grade III/IV Astrocytomas

This is a Phase I, dose-escalating study of the vaccine ADU-623 in patients with treated and recurrent high-grade astrocytomas. Key...

Marka Crittenden MD PhD
  • Compass Oncology East
  • Oncology and Hematology Care Eastside
  • Providence Portland Medical Center

Phase III Intergroup Study of Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma

This is a Phase III study that will compare the effectiveness of radiotherapy with temozolomide followed by temozolomide chemotherapy versus...

Alison Conlin MD
  • Clackamas Radiation Oncology Center
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

This is a randomized, phase II trial that will test the hypothesis that re-irradiation combined with an effective targeted agent, bevacizumab, will...

Matthew Solhjem MD
  • Clackamas Radiation Oncology Center
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)

This pilot clinical trial studies anastrozole in treating aromatase inhibitor musculoskeletal symptoms in female patients with stage I-III breast...

Kelly Perlewitz MD
  • Clackamas Radiation Oncology Center
  • Oncology and Hematology Care Southeast
  • Providence Milwaukie Hospital
  • Providence Newberg Medical Center
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
  • Providence Willamette Falls Medical Center
« Previous 12345 Next »
Viewing Page 1 of 19 | Showing Results 1 - 5 of 93